243 related articles for article (PubMed ID: 37325556)
1. Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma.
Zhang Z; Zhang F; Pang P; Li Y; Chen X; Sun S; Bian Y
Front Cell Dev Biol; 2023; 11():1210456. PubMed ID: 37325556
[TBL] [Abstract][Full Text] [Related]
2. PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer.
Wang X; Sun R; Chan S; Meng L; Xu Y; Zuo X; Wang Z; Hu X; Han Q; Dai L; Bai T; Yu Z; Wang M; Yang W; Zhang H; Chen W
Front Genet; 2022; 13():955355. PubMed ID: 36186438
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.
Li H; Li T; Zhang X
Front Mol Biosci; 2022; 9():822503. PubMed ID: 35309514
[TBL] [Abstract][Full Text] [Related]
4. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
[TBL] [Abstract][Full Text] [Related]
5. PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma.
Song F; Wang CG; Mao JZ; Wang TL; Liang XL; Hu CW; Zhang Y; Han L; Chen Z
Front Immunol; 2023; 14():1197152. PubMed ID: 37398672
[TBL] [Abstract][Full Text] [Related]
6. Identification of subtypes of hepatocellular carcinoma and screening of prognostic molecular diagnostic markers based on cell adhesion molecule related genes.
Sun R; Gao Y; Shen F
Front Genet; 2022; 13():1042540. PubMed ID: 36482887
[TBL] [Abstract][Full Text] [Related]
7. Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity.
Dai Q; Zhu J; Yang J; Zhang CY; Yang WJ; Pan BS; Yang XR; Guo W; Wang BL
Curr Stem Cell Res Ther; 2024 Mar; ():. PubMed ID: 38561604
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
[TBL] [Abstract][Full Text] [Related]
9. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J
J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051
[TBL] [Abstract][Full Text] [Related]
10. A Model of Basement Membrane-Associated Gene Signature Predicts Liver Hepatocellular Carcinoma Response to Immune Checkpoint Inhibitors.
Shen J; Wei Z; Lv L; He J; Du S; Wang F; Wang Y; Ni L; Zhang X; Pan F
Mediators Inflamm; 2023; 2023():7992140. PubMed ID: 37152370
[TBL] [Abstract][Full Text] [Related]
11. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.
Yan C; Niu Y; Ma L; Tian L; Ma J
J Transl Med; 2022 Oct; 20(1):452. PubMed ID: 36195876
[TBL] [Abstract][Full Text] [Related]
12. Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing chemotherapy and targeted therapy in liver hepatocellular carcinoma.
Pan Y; Zhu Q; Hong T; Cheng J; Tang X
Aging (Albany NY); 2024 May; 16():. PubMed ID: 38787389
[TBL] [Abstract][Full Text] [Related]
13. Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma.
Chen X; Yang M; Wang L; Wang Y; Tu J; Zhou X; Yuan X
BMC Cancer; 2023 May; 23(1):411. PubMed ID: 37149620
[TBL] [Abstract][Full Text] [Related]
14. The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.
Song J; Xu Z; Fan Q; Sun Y; Lin X
Front Mol Neurosci; 2023; 16():1198713. PubMed ID: 37501725
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma.
Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S
Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158
[No Abstract] [Full Text] [Related]
16. Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis.
He Q; Fan B; Du P; Jin Y
Front Cell Dev Biol; 2022; 10():806989. PubMed ID: 35356272
[No Abstract] [Full Text] [Related]
17. A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma.
Zhu J; Kuang J; Yang Y; Zhang L; Leng B; She R; Zou L
Mediators Inflamm; 2023; 2023():6645476. PubMed ID: 37114236
[TBL] [Abstract][Full Text] [Related]
18. Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer.
Zhao L; You Z; Bai Z; Xie J
Front Oncol; 2023; 13():1171878. PubMed ID: 37152064
[TBL] [Abstract][Full Text] [Related]
19. Construction of a machine learning-based artificial neural network for discriminating PANoptosis related subgroups to predict prognosis in low-grade gliomas.
Chen G; He Z; Jiang W; Li L; Luo B; Wang X; Zheng X
Sci Rep; 2022 Dec; 12(1):22119. PubMed ID: 36543888
[TBL] [Abstract][Full Text] [Related]
20. Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma.
Shi X; Gao X; Liu W; Tang X; Liu J; Pan D; Duan X; Jin Y; Ren W; Yang L; Liu W
Oncol Res; 2023; 31(4):569-590. PubMed ID: 37415742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]